re: News: Suda confirms excellent results fro... Hi Kippax
Yes agreed
I thought the content was excellent. And yes it could have been more broader but the interview was just in relation to the Phase 3 trial results.
As for marketing, I couldnt agree with you more.
SUDA is a compelling investment opportunity with a completed Phase 3 trial as its lead product, and adding to that this product is not just a "me too" product in a crowded marketplace but can make significant inroads in its chosen market given its benefits over existing treatments.
The BRR interview is a good one but yes, we need to get the story out there!
News: Suda confirms excellent results from ArTiMi, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.008(4.62%) |
Mkt cap ! $163.0M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.3¢ | 15.5¢ | $249.5K | 1.583M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2289 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 62493 | 1 |
View Market Depth
| Last trade - 15.30pm 02/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |